GPT Healthcare profitability ratios

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024

Returns
	16.3%	16.3%	21.4%	21.9%
	10.0%	10.0%	13.7%	13.8%
	16.4%	16.4%	22.2%	26.0%
	20.6%	18.4%	20.4%	22.5%
Margins
	18.5%	17.8%	20.5%	22.0%
	12.1%	12.1%	15.8%	17.5%
	—	−11.0%	−80.2%	—
	12.4%	11.6%	17.0%	17.0%
	9.6%	8.9%	12.3%	11.9%
	8.3%	8.3%	4.3%	12.4%
Additional
	22.3%	23.0%	28.0%	29.8%
	—	48.6%	57.5%	50.2%
	16.3%	8.4%	9.1%	10.9%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

GPTHEALTH₹136.89

GPT Healthcare Limited

· Pharma & Health

₹ CrorePeersGKSL SHALBY INDRAMEDCO LOTUSEYE ARTEMISMED DRAGARWQ KMCSHIL KOVAIMcap ₹1,123 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Returns
Return on Common Equity	21.86	21.41	16.32	16.32
Return on Assets	13.83	13.68	9.95	9.95
Return on Capital Employed	26.04	22.24	16.42	16.42
Return on Invested Capital	22.49	20.35	18.45	20.59
Margins
EBITDA Margin	21.95	20.48	17.81	18.51
Operating Margin	17.46	15.80	12.08	12.08
Incremental Operating Margin	—	-80.22	-11.04	—
Pretax Margin	17.00	17.03	11.60	12.38
Net Income Margin	11.94	12.26	8.93	9.61
FCF Margin	12.35	4.29	8.33	8.33
Additional
Effective Tax Rate	29.80	28.01	22.96	22.33
Dvd Payout Ratio	50.18	57.53	48.59	—
Sustainable Growth Rate	10.89	9.09	8.39	16.32

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.